VirginiaSB5922025 Regular SessionSenate

Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug.

Sponsored By: Saddam Azlan Salim (Democratic)

Failed

Summary

Department of Medical Assistance Services; Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug. Directs the Department of Medical Assistance Services to eliminate the requirement that a patient try and fail a drug from the Preferred Drug List/Common Core Formulary in the six months immediately prior to approval of a nonpreferred drug when such patient has previously tried the drug from the Preferred Drug List/Common Core Formulary and experienced harmful side effects.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Saddam Azlan Salim

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 15 • No: 0

Senate vote • 2/8/2024

Continued to 2025 in Education and Health

Yes: 15 • No: 0

Actions Timeline

  1. Left in Education and Health

    11/19/2024Senate
  2. Continued to 2025 in Education and Health (15-Y 0-N)

    2/8/2024Senate
  3. Assigned Education and Health Sub: Health

    2/5/2024Senate
  4. Impact statement from DPB (SB592)

    1/24/2024Senate
  5. Referred to Committee on Education and Health

    1/10/2024Senate
  6. Prefiled and ordered printed; offered 01/10/24 24103030D

    1/10/2024Senate

Bill Text

  • Introduced

    1/11/2024

Related Bills

Back to State Legislation